After the diagnosis of FD has been confirmed, and genetic mutational signatures have been generated—and enzyme activity levels measured—at what age can available therapies be started? And how long should patients be treated?

After the diagnosis of FD has been confirmed, and genetic mutational signatures have been generated—and enzyme activity levels measured—at what age can available therapies be started? And how long should patients be treated?

After the diagnosis of FD has been confirmed, and genetic mutational signatures have been generated—and enzyme activity levels measured—at what age can available therapies be started? And how long should patients be treated? 


Created by

CMEducation Resources IQ&A Fabry Disease Diagnostic Intelligence Zone

Presenter

Robert Hopkin

Robert Hopkin

Associate Professor of Clinical Pediatrics
Cincinnati Children's Hospital Medical Center
Co-Director, 22Q-VCFS Center
University of Cincinnati College of Medicine
Cincinnati, OH